Medical Marijuana Discouraged By Researchers In Studies

  • The U.S. federal government is still finding new ways to deter popularity and usefulness of medical marijuana despite the fact that the Obama administration has offered tacit support and giving hints and doing things to promote liberal medical marijuana laws. However, the Federal government is ignoring and delaying the legalizing process to make marijuana available for research.

    This can be evident from the fact Lyle E. Craker, a professor of plant sciences at the University of Massachusetts, applied nearly nine years ago to get permission from federal authorities and the Drug Enforcement Administration has refused permission. The worst part is that this was after the agency’s own administrative law judge ruled in 2007 that the application of Dr. Cracker should be approved.

    The fact that the federal government is trying every way is also evident from the comments made by a spokesman for National Institute on Drug Abuse. Shirley Simson said, “As the National Institute on Drug Abuse, our focus is primarily on the negative consequences of marijuana use,” and added, “We generally do not fund research focused on the potential beneficial medical effects of marijuana.

    It is worth noting that marijuana is the only major drug for which the federal government controls the only legal research supply, for which the government needs a special scientific review.

    Studies in the last few decades, especially the last few years, have shown that marijuana may improve appetite and relieve nausea among cancer patients undergoing chemotherapy. The drug also has the potential to alleviate the numbness and aching that are experienced by HIV and AIDS patients. Dr. Igor Grant, director of the Center for Medicinal Cannabis Research at the University of California, San Diego recently said that there are strong hints that the drug can ameliorate some of the neurological problems associated with degenerative diseases like multiple sclerosis.

  • Tags: , , , ,
  • Comments